AXT INC (AXTI)

US00246W1036 - Common Stock

3.015  -0.01 (-0.5%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AXTI. AXTI was compared to 107 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of AXTI have multiple concerns. AXTI is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

AXTI had negative earnings in the past year.
In the past year AXTI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AXTI reported negative net income in multiple years.
In multiple years AXTI reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -5.03%, AXTI is doing worse than 64.15% of the companies in the same industry.
With a Return On Equity value of -8.85%, AXTI is not doing good in the industry: 65.09% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -5.03%
ROE -8.85%
ROIC N/A
ROA(3y)1.17%
ROA(5y)0.66%
ROE(3y)1.67%
ROE(5y)1.02%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AXTI has a worse Gross Margin (17.58%) than 83.96% of its industry peers.
AXTI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AXTI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-13.43%

2

2. Health

2.1 Basic Checks

AXTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
AXTI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AXTI has been increased compared to 5 years ago.
The debt/assets ratio for AXTI is higher compared to a year ago.

2.2 Solvency

AXTI has an Altman-Z score of 0.71. This is a bad value and indicates that AXTI is not financially healthy and even has some risk of bankruptcy.
AXTI has a worse Altman-Z score (0.71) than 72.64% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that AXTI is not too dependend on debt financing.
The Debt to Equity ratio of AXTI (0.26) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 0.71
ROIC/WACCN/A
WACC11.36%

2.3 Liquidity

A Current Ratio of 2.09 indicates that AXTI has no problem at all paying its short term obligations.
The Current ratio of AXTI (2.09) is worse than 70.75% of its industry peers.
AXTI has a Quick Ratio of 1.03. This is a normal value and indicates that AXTI is financially healthy and should not expect problems in meeting its short term obligations.
AXTI has a Quick ratio of 1.03. This is amonst the worse of the industry: AXTI underperforms 80.19% of its industry peers.
Industry RankSector Rank
Current Ratio 2.09
Quick Ratio 1.03

4

3. Growth

3.1 Past

The earnings per share for AXTI have decreased strongly by -219.44% in the last year.
The Revenue for AXTI has decreased by -46.28% in the past year. This is quite bad
The Revenue has been decreasing by -5.84% on average over the past years.
EPS 1Y (TTM)-219.44%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-400%
Revenue 1Y (TTM)-46.28%
Revenue growth 3Y-7.38%
Revenue growth 5Y-5.84%
Revenue growth Q2Q-23.77%

3.2 Future

Based on estimates for the next years, AXTI will show a very strong growth in Earnings Per Share. The EPS will grow by 55.02% on average per year.
Based on estimates for the next years, AXTI will show a very strong growth in Revenue. The Revenue will grow by 33.82% on average per year.
EPS Next Y49%
EPS Next 2Y55.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year27.31%
Revenue Next 2Y33.82%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

AXTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AXTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

AXTI's earnings are expected to grow with 55.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.02%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AXTI!.
Industry RankSector Rank
Dividend Yield N/A

AXT INC

NASDAQ:AXTI (4/30/2024, 9:21:26 AM)

3.015

-0.01 (-0.5%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap133.41M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.03%
ROE -8.85%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 17.58%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.09
Quick Ratio 1.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-219.44%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y49%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-46.28%
Revenue growth 3Y-7.38%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y